Molecular features and vulnerabilities of recurrent chordomas

Abstract Background Tumor recurrence is one of the major challenges in clinical management of chordoma. Despite R0-resection, approximately 50% of chordomas recur within ten years after initial surgery. The underlying molecular processes are poorly understood resulting in the lack of associated ther...

Full description

Bibliographic Details
Main Authors: Carolin Seeling, André Lechel, Michael Svinarenko, Peter Möller, Thomas F. E. Barth, Kevin Mellert
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
HOX
PBX
Online Access:https://doi.org/10.1186/s13046-021-02037-y